Article

Neoplastic Diseases of the Peritoneum and Mesentery

1 Department of Radiology, Cork University Hospital, Wilton, Cork, Ireland.
American Journal of Roentgenology (Impact Factor: 2.74). 05/2013; 200(5):W420-30. DOI: 10.2214/AJR.12.8494
Source: PubMed
1 Follower
 · 
66 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The largest and most complex serosal membrane in the body, the peritoneum, lines the abdominal cavity, and the abdominopelvic viscera. It is frequently involved in a variety of benign and malignant processes. While secondary involvement of the peritoneum is more common, primary tumors can be a diagnostic challenge. Knowledge of the anatomy is crucial in understanding the various pathologic processes. Cross-sectional imaging plays an important role in diagnosing and evaluating the extent of the disease processes. This article reviews the imaging anatomy of the peritoneum and mesentery and the common pathologies involving it.
    Abdominal Imaging 09/2014; 40(3). DOI:10.1007/s00261-014-0232-8 · 1.73 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Most digestive malignancies have asymptomatic course, often progressing to poor outcome stages. Surgical resection usually represents the only potentially curative option but a prior assumption of the malignant nature of the lesion is mandatory to avoid exposing patients to unnecessary risks. Unfortunately, currently available diagnostic tools lack accuracy in many cases, so that more reliable markers are needed to improve detection of malignant lesions. In this challenging context, fluids surrounding digestive malignancies represent a valuable source for the search of new potential biomarkers and proteomic tools offer the opportunity to achieve this goal. The new field of proximal fluid proteomics is thus emerging in the arena of digestive cancer biomarker discovery. In the present review, the state-of-the-art of proteomic investigations aimed at identifying new cancer biomarkers in fluids surrounding gastrointestinal malignancies is summarized. A comprehensive catalogue of proteomic studies in which potential cancer biomarkers from gastrointestinal fluids have been identified and assessed for their diagnostic performances is also provided.
    Biochimica et Biophysica Acta 10/2013; 1844(5). DOI:10.1016/j.bbapap.2013.10.011 · 4.66 Impact Factor